Category: ACE2 Receptors

Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management

Posted on | Posted on John Murphy | Leave a Comment on Cardiorespiratory dysautonomia in post-COVID-19 condition: Manifestations, mechanisms and management

Artur Fedorowski, Monika Fagevik Olsén, Frida Nikesjö, Christer Janson, Judith Bruchfeld, Maria Lerm, Kristofer Hedma: May 2023, Journal of Internal MedicineVolume 294, Issue 5 p. 548-562 Abstract A significant proportion of COVID-19 patients experience debilitating symptoms for months after the acute infection. According to recent estimates, approximately 1 out of 10 COVID-19 convalescents reports persistent health issues more than 3 months after […]

Study identifies potential cause of long COVID muscle weakness

Posted on | Posted on John Murphy | Leave a Comment on Study identifies potential cause of long COVID muscle weakness

by University of Malta, Medical Express, Aug 2023 University of Malta researchers have discovered a potential cause of the persistent and often debilitating symptoms experienced by long COVID-19 patients. The new study published in Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease has implications on the development of medications to treat individuals that have not completely recovered from […]

Dysgeusia in COVID-19: Possible Mechanisms and Implications

Posted on | Posted on John Murphy | Leave a Comment on Dysgeusia in COVID-19: Possible Mechanisms and Implications

Francina Lozada-Nur, DDS, MS, MPH,a Nita Chainani-Wu, DMD, MS, MPH, PhD,b Giulio Fortuna, DMD, PhD,c and Herve Sroussi, DMD, PhDd : Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Sep; 130(3): 344–doi: 10.1016/j.oooo.2020.06.016, PMCID: PMC7320705, PMID: 32703719 For the purpose of this letter to the editor, we will focus solely on new-onset dysgeusia as a potential early marker of COVID-19 infection and […]

COVID-19 and emerging spinal cord complications: A systematic review

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and emerging spinal cord complications: A systematic review

Ritwick Mondal,a Shramana Deb,b Gourav Shome,c Upasana Ganguly,a Durjoy Lahiri,a,d,⁎ and Julián Benito-Leóne,f,g,⁎⁎ Mult Scler Relat Disord. 2021 Jun; 51: 102917.Published online 2021 Mar 21. doi: 10.1016/j.msard.2021.102917 PMCID: PMC7981271 PMID: 33845350 Abstract Background : Spinal cord complications associated with coronavirus infectious disease of 2019 (COVID-19) are being widely reported. The purpose of this systematic review was to summarize so far available pieces of evidence documenting de novo novel severe […]

Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

Posted on | Posted on John Murphy | Leave a Comment on Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

Suo-wen Xu, Iqra Ilyas & Jian-ping Weng  Acta Pharmacologica Sinica volume 44, pages695–709 (2023) Cite this article 17 October 2022 Abstract The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is still raging. However, the pathophysiology of acute and post-acute manifestations of COVID-19 (long COVID-19) is understudied. Endothelial cells are sentinels lining the innermost layer of blood vessel that […]

COVID-19 Shot May Be Linked To Unexpected Vaginal Bleeding: Study

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 Shot May Be Linked To Unexpected Vaginal Bleeding: Study

THURSDAY, OCT 05, 2023 – 09:20 PM Authored by Mary Gillis The Epoch Times  Norwegian scientists have discovered an unusual side effect in COVID-19-vaccinated women who don’t menstruate: atypical vaginal bleeding after injection with the Moderna and Pfizer vaccines. Researchers studied close to 22,000 women across different reproductive aging stages over about nine months and found […]

Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

Posted on | Posted on John Murphy | Leave a Comment on Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies

Suo-wen Xu, Iqra Ilyas & Jian-ping Weng Acta Pharmacologica Sinica volume 44, pages695–709 (2023) Nature Abstract The fight against coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is still raging. However, the pathophysiology of acute and post-acute manifestations of COVID-19 (long COVID-19) is understudied. Endothelial cells are sentinels lining the innermost layer of blood vessel that gatekeep micro- and macro-vascular health by […]

COVID Tongue: How a Swollen Tongue Could Indicate COVID-19

Posted on | Posted on John Murphy | Leave a Comment on COVID Tongue: How a Swollen Tongue Could Indicate COVID-19

Should you be examining your tongue? Here’s how to tell if it’s COVID tongue and how to treat it. By  Korin Miller September 22, 2023; Medically reviewed by  Michael Menna, DO HEALTH You may have heard of COVID-19 causing loss of taste and smell, COVID toes, and unusual skin rashes, but did you know COVID can affect […]

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside

David Sulzer, Angelo Antonini, Valentina Leta, Anna Nordvig, Richard J. Smeyne, James E. Goldman, Osama Al-Dalahmah, Luigi Zecca, Alessandro Sette, Luigi Bubacco, Olimpia Meucci, Elena Moro, Ashley S. Harms, Yaqian Xu, Stanley Fahn & K. Ray Chaudhuri  npj Parkinson’s Disease volume 6, Article number: 18 (2020) Cite this article Abstract This Viewpoint discusses insights from basic science and clinical perspectives on coronavirus disease 2019 (COVID-19)/severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection in the brain, with a particular focus […]

Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis

Posted on | Posted on John Murphy | Leave a Comment on Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: The role of Epstein–Barr virus and the gut–brain axis

Kenji Hashimoto, Molecular Psychiatry (2023) Published: 04 July 2023 Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in a serious public health burden worldwide. In addition to respiratory, heart, and gastrointestinal symptoms, patients infected with SARS-CoV-2 experience a number of persistent neurological and psychiatric symptoms, known as […]